JPY 1090.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 324.19 Million JPY | -0.84% |
2022 | 327.31 Million JPY | 27.94% |
2021 | 255.83 Million JPY | 7.32% |
2020 | 238.37 Million JPY | 9.85% |
2019 | 217 Million JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 110 Million JPY | 11.54% |
2023 Q2 | 69.15 Million JPY | -8.84% |
2023 Q4 | 98.62 Million JPY | 21.84% |
2023 Q3 | 80.94 Million JPY | 17.06% |
2023 FY | 324.56 Million JPY | -0.84% |
2023 Q1 | 75.85 Million JPY | -0.76% |
2022 Q3 | 84 Million JPY | 10.05% |
2022 FY | 327.31 Million JPY | 27.94% |
2022 Q4 | 76.43 Million JPY | -9.01% |
2022 Q2 | 76.32 Million JPY | 0.0% |
2021 FY | 255.83 Million JPY | 7.32% |
2020 FY | 238.37 Million JPY | 9.85% |
2019 FY | 217 Million JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 9.85 Billion JPY | 96.712% |
Cosmo Bio Company,Limited | 2.73 Billion JPY | 88.129% |
H.U. Group Holdings, Inc. | 67.27 Billion JPY | 99.518% |
FALCO HOLDINGS Co., Ltd. | 10.77 Billion JPY | 96.99% |
BML, Inc. | 36.46 Billion JPY | 99.111% |
Human Metabolome Technologies, Inc. | 639.4 Million JPY | 49.297% |
Precision System Science Co., Ltd. | 1.9 Billion JPY | 82.996% |